Search research articles
Contact Us
Filters
Showing results (171-180 of 193) with videos related to
Page
of 20
Sort By:
Journal of the American Society of Nephrology : JASN
|
December 16, 2016
Thrombotic Microangiopathy in Inverted Formin 2<i>-</i>Mediated Renal Disease
Rachel C Challis, Troels Ring, Yaobo Xu, et al.
Investigative Ophthalmology & Visual Science
|
July 2, 2010
Complement factor h autoantibodies and age-related macular degeneration
Baljean Dhillon, Alan F Wright, Adnan Tufail, et al.
Health Technology Assessment (Winchester, England)
|
March 3, 2026
Clinical and cost-effectiveness of eculizumab withdrawal in atypical haemolytic uraemic syndrome: the SETS aHUS multi-centre, open-label, prospective and single-arm study
Andrew Bryant, Jan Lecouturier, Giovany Orozco-Leal, et al.
Kidney Medicine
|
August 6, 2024
Ravulizumab in Atypical Hemolytic Uremic Syndrome: An Analysis of 2-Year Efficacy and Safety Outcomes in 2 Phase 3 Trials
Bradley P Dixon, David Kavanagh, Alvaro Domingo Madrid Aris, et al.
Human Mutation
|
June 21, 2021
Prevalence and phenotype associations of complement factor I mutations in geographic atrophy
Adnan H Khan, Janice Sutton, Angela J Cree, et al.
Molecular Immunology
|
June 23, 2012
Factor H autoantibodies in membranoproliferative glomerulonephritis
Timothy H J Goodship, Isabel Y Pappworth, Tibor Toth, et al.
Nature Communications
|
October 12, 2018
Complement receptor CD46 co-stimulates optimal human CD8<sup>+</sup> T cell effector function via fatty acid metabolism
Giuseppina Arbore, Erin E West, Jubayer Rahman, et al.
Nature Reviews. Nephrology
|
January 30, 2019
C3 glomerulopathy - understanding a rare complement-driven renal disease
Richard J H Smith, Gerald B Appel, Anna M Blom, et al.
Journal of the American Society of Nephrology : JASN
|
April 12, 2014
Characterization of a factor H mutation that perturbs the alternative pathway of complement in a family with membranoproliferative GN
Edwin K S Wong, Holly E Anderson, Andrew P Herbert, et al.
Kidney International Reports
|
December 18, 2023
Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy
Edwin Wong, Carla Nester, Teresa Cavero, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 193) with videos related to
Sort By:
Page
of 20
Journal of the American Society of Nephrology : JASN
|
December 16, 2016
Thrombotic Microangiopathy in Inverted Formin 2<i>-</i>Mediated Renal Disease
Rachel C Challis, Troels Ring, Yaobo Xu, et al.
Investigative Ophthalmology & Visual Science
|
July 2, 2010
Complement factor h autoantibodies and age-related macular degeneration
Baljean Dhillon, Alan F Wright, Adnan Tufail, et al.
Health Technology Assessment (Winchester, England)
|
March 3, 2026
Clinical and cost-effectiveness of eculizumab withdrawal in atypical haemolytic uraemic syndrome: the SETS aHUS multi-centre, open-label, prospective and single-arm study
Andrew Bryant, Jan Lecouturier, Giovany Orozco-Leal, et al.
Kidney Medicine
|
August 6, 2024
Ravulizumab in Atypical Hemolytic Uremic Syndrome: An Analysis of 2-Year Efficacy and Safety Outcomes in 2 Phase 3 Trials
Bradley P Dixon, David Kavanagh, Alvaro Domingo Madrid Aris, et al.
Human Mutation
|
June 21, 2021
Prevalence and phenotype associations of complement factor I mutations in geographic atrophy
Adnan H Khan, Janice Sutton, Angela J Cree, et al.
Molecular Immunology
|
June 23, 2012
Factor H autoantibodies in membranoproliferative glomerulonephritis
Timothy H J Goodship, Isabel Y Pappworth, Tibor Toth, et al.
Nature Communications
|
October 12, 2018
Complement receptor CD46 co-stimulates optimal human CD8<sup>+</sup> T cell effector function via fatty acid metabolism
Giuseppina Arbore, Erin E West, Jubayer Rahman, et al.
Nature Reviews. Nephrology
|
January 30, 2019
C3 glomerulopathy - understanding a rare complement-driven renal disease
Richard J H Smith, Gerald B Appel, Anna M Blom, et al.
Journal of the American Society of Nephrology : JASN
|
April 12, 2014
Characterization of a factor H mutation that perturbs the alternative pathway of complement in a family with membranoproliferative GN
Edwin K S Wong, Holly E Anderson, Andrew P Herbert, et al.
Kidney International Reports
|
December 18, 2023
Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy
Edwin Wong, Carla Nester, Teresa Cavero, et al.
Page
of 20